You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Brain cancers

Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

  • Technology appraisal guidance
  • Reference number: TA121
  • Published:  27 June 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders Appendix A: provisional matrix of stakeholders
27 August 2010
(30.83 Kb 8 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 31 December 2010

Back to top